
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Director Market Access
Munich, Germany | full time | Job ID: 11382
Your Role:
As Director Market Access, you will be responsible for the strategic and operational management of market access activities in Germany. The focus will be on our innovative oncology products and vaccines. In this role, you will combine leadership skills, strategic expertise, and close collaboration with internal and external stakeholders to ensure sustainable access to our therapies within the German healthcare system. You will be part of a dynamic, interdisciplinary team dedicated to shaping the future of medicine.
Your Contribution:
Strategic Responsibility for Market Access in Germany:
- Development and implementation of the market access strategy for the German portfolio (oncology & vaccines).
- Management of AMNOG processes, including leading dossier preparation, benefit assessments, negotiation preparation, and execution.
- Responsibility for pricing strategies, price negotiations, and long-term price positioning within the statutory health insurance system (GKV), aligned with global pricing.
Management of Reimbursement and Care Processes:
- Ensuring reimbursement within the statutory health insurance system through all relevant mechanisms (e.g., adjustments or negotiation of reimbursement systems, KV processes, selective contracts).
- In-depth knowledge of EBM and DRG coding, including evaluation of new procedures, billing pathways, and remuneration logics.
- Close collaboration with KVs (regional associations of statutory health insurance physicians), health insurance funds, and other stakeholders.
- Close cooperation with Governmental Affairs, especially regarding expert input for policy briefings and strategic positioning. Participation in committees and meetings with political stakeholders while contributing your expertise.
Team Leadership and Internal Collaboration:
- Leading and developing an interdisciplinary market access team.
- Close coordination with Medical Affairs, HEOR (Health Economics & Outcomes Research), Commercial, Regulatory Affairs, Marketing, and Governmental Affairs.
- Promoting a data-driven and collaborative work culture.
Evidence Generation and Economic Evaluation:
- Assessment and utilization of RWE studies (Real World Evidence), particularly based on health insurance data, care research, and registry data.
- Incorporation of health economic models (e.g., budget impact analyses, cost-effectiveness models) to support pricing and reimbursement arguments.
- Identification of evidence gaps, input into evidence generation plans, and initiation of corresponding study programs.
A Good Match:
- Completed studies in health economics, medicine, pharmacy, public health or a comparable qualification
- Several (5+) years of experience in market access in Germany; ideally in oncology or vaccine development
- Profound knowledge of AMNOG processes, GKV structures, EBM/DRG systems as well as pricing mechanisms
- Leadership experience with interdisciplinary teams and management of complex stakeholder landscapes
- Knowledge in RWE generation and health economic models is a plus
- Strong communication skills combined with negotiation expertise and strategic thinking
- Analytical competence paired with structured working methods; ability to convey complex issues clearly
- Confident demeanor when interacting with authorities, insurers, medical societies as well as internal decision-makers
Your Benefits:
BioNTech is committed to the wellbeing of our team members and offers a variety of benefits in support of our diverse employee base. We offer competitive remuneration packages which is determined by the specific role, location of employment and also the selected candidate’s qualifications and experience.
Note: The availability, eligibility and design of the listed benefits may vary depending on the location. The final requirements for the individual use of our benefits are based on the company's internal policies and applicable law.
How to apply:
Apply now by sending us your application documents including Curriculum Vitae, copy of ID, copies of degree certificates and professional certificates, motivation letter as well as your contact details via our online form.
Please note:
Only applications sent via our online form shall be considered. By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
We are looking forward receiving your application.
浏览量
0
申请点击
0
Mock Apply
0
收藏
0
相似职位

Senior Program Manager - Hardware (Platforms)
Qualcomm · Hyderabad, Telangana, India

Director, Technical Writing
GitLab · Remote, Canada; Remote, US

Lead Product Manager - Technical
Mastercard · O'Fallon, Missouri

Senior Director
Curtiss-Wright · New York, New York, USA

IT Audit Project Manager
Regions Financial · Hoover, Alabama, United States of America
关于BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
员工数
Mainz that develops immunotherapies
总部位置
$21.7B
企业估值
评价
10条评价
4.0
10条评价
工作生活平衡
2.8
薪酬
3.7
企业文化
4.2
职业发展
3.5
管理层
3.3
78%
推荐率
优点
Innovative and cutting-edge technology projects
Supportive and collaborative team environment
Meaningful and impactful work with strong mission
缺点
Long working hours and high workload
Fast-paced environment can be stressful
High pressure and expectations
薪资范围
38个数据点
M3
M4
M5
M6
Mid/L4
Intern
L4
M3 · Product Manager M3
0份报告
$66,002
年薪总额
基本工资
$26,401
股票
$33,001
奖金
$6,600
$46,201
$85,803
面试评价
1条评价
难度
3.0
/ 5
时长
14-28周
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
常见问题
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
最新动态
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
WSJ
News
·
2w ago
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
News
·
2w ago
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2w ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3w ago